2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
25
Peritoneal Neoplasms
17
Fallopian Tube Neoplasms
11
Colorectal Neoplasms
8
Stomach Neoplasms
6
Carcinoma, Ovarian Epithelial
6
Neoplasms
3
Hyperthermia
3
Gastrointestinal Neoplasms
3
Colonic Neoplasms
3
Appendiceal Neoplasms
3
Adrenocortical Carcinoma
3
Sarcoma
2
Rhabdomyosarcoma
2
Recurrence
2
Mesothelioma, Malignant
2
Mesothelioma
2
Glioma
2
Glioblastoma
2
Desmoplastic Small Round Cell Tumor
2
Carcinoma
2
Brain Neoplasms
2
Adenoma, Islet Cell
2
Wilms Tumor
1
Retroperitoneal Neoplasms
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Postoperative Complications
1
Pleural Effusion, Malignant
1
Peritoneal Cavity Cancer
1
Interventions
pembrolizumab
157
Gemcitabine
140
Capecitabine
123
Paclitaxel
121
Fluorouracil
117
Oxaliplatin
110
Bevacizumab
106
Nivolumab
99
Docetaxel
98
Leucovorin
97
Cisplatin
90
Radiosurgery
88
Irinotecan
88
Carboplatin
86
Cyclophosphamide
72
Cetuximab
72
Magnetic Resonance Spectroscopy
68
Specimen Handling
60
Radiotherapy
60
Trastuzumab
59
Biopsy
59
Ipilimumab
53
Drug Therapy
51
Everolimus
48
Pemetrexed
46
Albumin-Bound Paclitaxel
45
130-nm albumin-bound paclitaxel
44
Doxorubicin
42
Fulvestrant
40
aldesleukin
37
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Cytoreduction Surgical Procedures
×
Clear all
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled